Mendelian Randomization Analysis: Type 2 Diabetes and Alzheimer's Disease

By Dr. Shea Andrews, generated on 2018-08-24


## [1] FALSE

Data sources

Type 2 Diabetes Xu et al Nature Genet 2018: Here we conduct a meta-analysis of genome-wide association studies (GWAS) with ~16 million genetic variants in 62,892 T2D cases and 596,424 controls of European ancestry by combining 3 GWAS data sets of European ancestry: DIAbetes Genetics Replication and Meta-analysis (DIAGRAM), Genetic Epidemiology Research on Aging (GERA), and the full cohort release of the UK Biobank (UKB). We identify 139 common and 4 rare variants associated with T2D, 42 of which (39 common and 3 rare variants) are independent of the known variants.

Late Onset Alzheimer’s disease (LOAD, Lambert et al 2013): The International Genomics of Alzheimer’s Project (IGAP) is a meta-analysis of 4 previously published GWAS datasets: the European Alzheimer’s Disease Imitative (EADI), the Alzheimer Disease Genetics Consortium (ADGC), Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE), and Genetic and Environmental Risk in AD (GERAD) and includes a sample of 17,008 LOAD cases and 37,154 cognitively normal elder controls. Participants in IGAP were of European ancestry, the average age was 71 and 58.4% of participants were women.

Alzheimer’s Age of Onset Surivial (AAOS, Huang et al 2017): A GWAS of age of onset in LOAD was conducted in 14,406 AD case samples and 25,849 control samples from the IGAP using Cox proportional hazard regressions. Participants were of European ancestry, in cases the the average AAO was 74.8 and 61.7% were women, in controls the average AAE was 79.0 and 59.6% were women.

CSF Ab42, tau & ptau (AB42, ptau, tau, Deming et al 2017): A GWAS of CSF AB42, ptau and tau levels (pg/mL) was conducted in 3,146 participants. Participants were of Eurpean ancestry.

Instrumental Vaibles

LD Clumping: For standard two sample MR it is important to ensure that the instruments for the exposure are independent. LD clumping can be performed using the data_clump function from the TwoSampleMR package, which uses EUR samples from the 1000 genomes project to estimate LD between SNPs and amonst SNPs that have and LD above a given threshold, only the SNP with the lowest p-value will be retained.

Proxy SNPs: SNPs associated with Type 2 Diabetes were extracted from the GWAS of LOAD, AAOS, AB42, ptau and tau. Where SNPs were not available in the outcome GWAS, the EUR thousand genomes was queried to identified potential proxy SNPs that are in linkage disequilibrium (r2 > 0.8) of the missing SNP.

Type 2 Diabetes

Type 2 Diabetes: 14452 SNPs (Table 1) were assoicated with were associated with Type 2 Diabetes at p < 5e-6. After LD clumping, 14012 of 14452 SNPs were removed.

Table 1: Independent SNPS associated with Type 2 Diabetes


LOAD

Of the the 440 SNPs associated with Type 2 Diabetes, 414 were available in the LOAD GWAS (Table 2).

Table 2: SNPS associated with Type 2 Diabetes avalible in LOAD GWAS


AAOS

Of the the 440 SNPs associated with Type 2 Diabetes, 440 were available in the AAOS GWAS (Table 3).

Table 3: SNPS associated with available in AAOS GWAS


AB42

Of the the 440 SNPs associated with Type 2 Diabetes, 382 were available in the CSF AB42 GWAS (Table 4).

Table 4: SNPS associated with Type 2 Diabetes avalible in ab42 GWAS


Ptau

Of the the 440 SNPs associated with Type 2 Diabetes, 413 were available in the CSF Ptau GWAS (Table 5).

Table 5: SNPS associated with Type 2 Diabetes avalible in Ptau GWAS


Tau

Of the the 440 SNPs associated with Type 2 Diabetes, 382 were available in the CSF Tau GWAS (Table 6).

Table 6: SNPS associated with Type 2 Diabetes avalible in tau GWAS


Data harmonization

Harmonize the exposure and outcome datasets so that the effect of a SNP on the exposure and the effect of that SNP on the outcome correspond to the same allele. The harmonise_data function from the TwoSampleMR package can be used to perform the harmonization step, by default it try’s to infer the forward strand alleles using allele frequency information. EAF were not availbe in the IGAP summary statisitics, as such the allele frequencies reported in the AAOS anaylsis were used.

Type 2 Diabetes ~ LOAD

Table 7: Harmonized Type 2 Diabetes and LOAD datasets


Type 2 Diabetes ~ AAOS

Table 8: Harmonized Type 2 Diabetes and AAOS datasets


Type 2 Diabetes ~ AB42

Table 9: Harmonized Type 2 Diabetes and AB42 datasets


Type 2 Diabetes ~ Ptau

Table 10: Harmonized Type 2 Diabetes and Ptau datasets


Type 2 Diabetes ~ Tau

Table 11: Harmonized Type 2 Diabetes and Tau datasets



Pleiotropy

Pleiotropy was assesed using Mendelian Randomization Pleiotropy RESidual Sum and Outlier (MR-PRESSO), that allows for the evlation of evaluation of horizontal pleiotropy in a standared MR model. MR-PRESSO performs a global test for detection of horizontal pleiotropy and correction of pleiotropy via outlier removal.

Type 2 Diabetes ~ LOAD: The MR-PRESSO global test for pleiotropy was significant (p = <1e-04). The following SNPs were removed due to pleiotropy: rs10410910, rs1063355, rs11039266

Type 2 Diabetes ~ AAOS: The MR-PRESSO global test for pleiotropy was significant (p = <1e-04). The following SNPs were removed due to pleiotropy: No significant outliers

Type 2 Diabetes ~ AB42: The MR-PRESSO global test for pleiotropy was significant (p = 0.0126).. The following SNPs were removed due to pleiotropy: rs77614642

Type 2 Diabetes ~ Ptau: The MR-PRESSO global test for pleiotropy was non-significant.

Type 2 Diabetes ~ Tau: The MR-PRESSO global test for pleiotropy was non-significant..

Mendelian Randomization Analysis

To obtain an overall estimate of causal effect, the SNP-exposure (Major Depressive Disorder) and SNP-outcome coefficients (Alzheimer’s disease and Alzheimer’s Age of Onset) were combined in 1) a random-effects meta-analysis using an inverse-variance weighted approach (IVW); 2) a Weighted Median approach; 3) and Egger Regression. IVW is equivalent to a weighted regression of the SNP-outcome coefficients on the SNP-exposure coefficients with the intercept constrained to zero. This method assumes that all variants are valid instrumental variables based on the Mendelian randomization assumptions. The causal estimate of the IVW analysis expresses the causal increase in the outcome (or log odds of the outcome for a binary outcome) per unit change in the exposure. Weighted median MR allows for 50% of the instrumental variables to be invalid. MR-Egger regression allows all the instrumental variables to be subject to direct effects (i.e. horizontal pleiotropy), with the intercept representing bias in the causal estimate due to pleiotropy and the slope representing the causal estimate.

Type 2 Diabetes ~ LOAD


Figure 1 illustrates the SNP-specific associations with Type 2 Diabetes versus the association between each SNP and risk of LOAD.

Fig. 1: Scatterplot of SNP effects for the association of Trait and LOAD

Fig. 1: Scatterplot of SNP effects for the association of Trait and LOAD


Figure 2 and Table 1 shows the SNP-specific effects and overall IVW, weighted median and Egger regression causal estimates of genetically predicted Type 2 Diabetes on risk of LOAD.

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations


Table 1: MR estimates for Type 2 Diabetes and LOAD


Figure 3 shows a funnel plot to detect pleiotropy and Table 2 show the results of Cochrans Q heterogeneity test to assess for the presence of pleiotropy.

Fig. 3: Funnel plot of the Trait – LOAD causal estimates against their precession

Fig. 3: Funnel plot of the Trait – LOAD causal estimates against their precession


Table 2: Heterogenity tests for Type 2 Diabetes and LOAD

## Warning in mr_heterogeneity(trait_LOAD.MRdat, method_list =
## c("mr_egger_regression", : Prior to version 0.4.9 there was a bug in
## the IVW Q statistic estimate, leading to a slight underestimation in
## heterogeneity. This has now been resolved.
Table 3: Test for directional pleitropy for Type 2 Diabetes and LOAD

Type 2 Diabetes ~ AAOS


Figure 4 illustrates the SNP-specific associations with Type 2 Diabetes versus the association between each SNP and AAOS.

Fig. 4: Scatterplot of SNP effects for the association of Trait and AAOS

Fig. 4: Scatterplot of SNP effects for the association of Trait and AAOS


Figure 5 and Table 4 shows the SNP-specific effects and overall IVW, weighted median and Egger regression causal estimates of genetically predicted Type 2 Diabetes on AAOS.

Fig. 5: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations

Fig. 5: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations


Table 4: MR estimates for Type 2 Diabetes and AAOS


Figure 6 shows a funnel plot to detect pleiotropy and Table 5 show the results of Cochrans Q heterogeneity test to assess for the presence of pleiotropy.

Fig. 6:  Funnel plot of the traitohol Conumption – AAOS causal estimates against their precession

Fig. 6: Funnel plot of the traitohol Conumption – AAOS causal estimates against their precession


Table 5: Heterogenity tests for Type 2 Diabetes and AAOS

## Warning in mr_heterogeneity(trait_AAOS.MRdat, method_list =
## c("mr_egger_regression", : Prior to version 0.4.9 there was a bug in
## the IVW Q statistic estimate, leading to a slight underestimation in
## heterogeneity. This has now been resolved.
Table 6: Test for directional pleitropy for Type 2 Diabetes and AAOS

Type 2 Diabetes ~ AB42


Figure 1 illustrates the SNP-specific associations with Type 2 Diabetes versus the association between each SNP and AB42.

Fig. 1: Scatterplot of SNP effects for the association of trait and AB42

Fig. 1: Scatterplot of SNP effects for the association of trait and AB42


Figure 2 and Table 7 shows the SNP-specific effects and overall IVW, weighted median and Egger regression causal estimates of genetically predicted Type 2 Diabetes CSF AB42 levels.

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations


Table 7: MR estimates for Type 2 Diabetes and AB42


Figure 3 shows a funnel plot to detect pleiotropy and Table 8 show the results of Cochrans Q heterogeneity test to assess for the presence of pleiotropy.

Fig. 3: Funnel plot of the trait – AB42 causal estimates against their precession

Fig. 3: Funnel plot of the trait – AB42 causal estimates against their precession


Table 8: Heterogenity tests for Type 2 Diabetes and AB42

## Warning in mr_heterogeneity(trait_AB42.MRdat, method_list =
## c("mr_egger_regression", : Prior to version 0.4.9 there was a bug in
## the IVW Q statistic estimate, leading to a slight underestimation in
## heterogeneity. This has now been resolved.
Table 9: Test for directional pleitropy for Type 2 Diabetes and AB42

Type 2 Diabetes ~ Ptau


Figure 1 illustrates the SNP-specific associations with Type 2 Diabetes versus the association between each SNP and risk of Ptau.

Fig. 1: Scatterplot of SNP effects for the association of trait and Ptau

Fig. 1: Scatterplot of SNP effects for the association of trait and Ptau


Figure 2 and Table 9 shows the SNP-specific effects and overall IVW, weighted median and Egger regression causal estimates of genetically predicted Type 2 Diabetes on risk of Ptau.

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations


Table 9: MR estimates for Type 2 Diabetes and Ptau


Figure 3 shows a funnel plot to detect pleiotropy and Table 10 show the results of Cochrans Q heterogeneity test to assess for the presence of pleiotropy.

Fig. 3: Funnel plot of the trait – Ptau causal estimates against their precession

Fig. 3: Funnel plot of the trait – Ptau causal estimates against their precession


Table 10: Heterogenity tests for Type 2 Diabetes and Ptau

## Warning in mr_heterogeneity(trait_Ptau.MRdat, method_list =
## c("mr_egger_regression", : Prior to version 0.4.9 there was a bug in
## the IVW Q statistic estimate, leading to a slight underestimation in
## heterogeneity. This has now been resolved.
Table 11: Test for directional pleitropy for Type 2 Diabetes and Ptau

Type 2 Diabetes ~ Tau


Figure 1 illustrates the SNP-specific associations with Type 2 Diabetes versus the association between each SNP and CSF Tau levels.

Fig. 1: Scatterplot of SNP effects for the association of trait and Tau

Fig. 1: Scatterplot of SNP effects for the association of trait and Tau


Figure 2 and Table 12 shows the SNP-specific effects and overall IVW, weighted median and Egger regression causal estimates of genetically predicted Type 2 Diabetes on risk of Tau.

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations

Fig. 2: Forrest plot of Wald ratios and 95% CIs for SNP-specific and overall IVW, Weighted median and Egger associations


Table 12: MR estimates for Type 2 Diabetes and Tau


Figure 3 shows a funnel plot to detect pleiotropy and Table 13 show the results of Cochrans Q heterogeneity test to assess for the presence of pleiotropy.

Fig. 3: Funnel plot of the trait – Tau causal estimates against their precession

Fig. 3: Funnel plot of the trait – Tau causal estimates against their precession


Table 14: Heterogenity tests for Type 2 Diabetes and Tau

## Warning in mr_heterogeneity(trait_Tau.MRdat, method_list =
## c("mr_egger_regression", : Prior to version 0.4.9 there was a bug in
## the IVW Q statistic estimate, leading to a slight underestimation in
## heterogeneity. This has now been resolved.
Table 15: Test for directional pleitropy for Type 2 Diabetes and Tau

MR analysis results